What do systematic reviews say?

Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA

• Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 779 participants
  Very low

Occupational therapy vs delivery by non‐specialists

The review found no eligible studies for this question.

• Occupational therapy delivered by specialists versus non‐specialists for people with schizophrenia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: Trihexyphenidyl vs placebo

The review found no eligible studies for this question.

• Trihexyphenidyl for dystonia in cerebral palsy 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oral + inhaled dual therapy vs oral monotherapy

• Dual antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Aspirin vs placebo

The review found no eligible studies for this question.

• Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

ASA with LMWH vs placebo or IVIG

The review found no eligible studies for this question.

• Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

ASA + high‐dose LMWH vs ASA + low‐dose LMWH or UFH

The review found no eligible studies for this question.

• Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Anticoagulant with or without ASA vs ASA only

The review found no eligible studies for this question.

• Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid… 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Olanzapine vs NK1 antagonist

The review found no eligible studies for this question.

• Olanzapine for the prevention and treatment of cancer‐related nausea and vomiting in adults 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Olanzapine vs placebo/no treatment

The review found no eligible studies for this question.

• Olanzapine for the prevention and treatment of cancer‐related nausea and vomiting in adults 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Polymyxins vs aminoglycosides

The review found no eligible studies for this question.

• Head‐to‐head trials of antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Fluoroquinolones vs amoxicillin

The review found no eligible studies for this question.

• Head‐to‐head trials of antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

TENS vs sham

• Non‐pharmacological interventions for chronic pain in multiple sclerosis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 90 participants
  Very low

Ai Chi Exercises vs sham

• Non‐pharmacological interventions for chronic pain in multiple sclerosis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 73 participants
  Very low

Intervention not reported

• Home parenteral nutrition for people with inoperable malignant bowel obstruction 2018 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 188 participants
  Very low

Cannabis oil (5% cannabidiol sublingual oil) vs placebo oil

The review found no eligible studies for this question.

• Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupuncture vs sham

The review found no eligible studies for this question.

• Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupuncture vs NSAIDs

The review found no eligible studies for this question.

• Acupuncture for hip osteoarthritis 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Amifostine vs no treatment/placebo

Amifostine showed no clear difference in quality of life compared with no treatment/placebo; GRADE not reported.

• Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy 2017 · Cochrane All outcomes

  End of RT; up to 3 months postRT
  MD 0.52 [-0.02, 1.06]
  1 study · 233 participants
  GRADE not reported

Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo

The review found no eligible studies for this question.

• Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomes
  No studies reported this outcome (planned secondary outcome not measured by any study in the review)
  0 studies
  No studies found